Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Peritoneal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Irinotecan 6S 1 (combination) 4Oxaliplatin 3palbociclib 2durvalumab 2Tamoxifen 2Radiation 2Erlotinib Hydrochloride 2Cetuximab 2Capecitabine 2tremelimumab 1trametinib 1titanium silicide 1sintilimab 1olaparib 1nilotinib 1glasdegib 1genexol-PM 1futibatinib 1dabrafenib 1ceritinib 1capmatinib 1anlotinib 1Temozolomide 1Talc 1Surgical Procedures, Operative 1Radiosurgery 1Pancreatectomy 1Paclitaxel 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasm Metastasis × Pancreatectomy × Clear all
NCT07493421 2026-03-25

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Unidade Local de Saúde São João

Phase NA Recruiting
20 enrolled
GastrointestinalGynecologic

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡